ALACHUA, Fla. (December 8, 2016) – RTI Surgical (RTI) (Nasdaq: RTIX), a global surgical implant company, announced today that its C-Plus™ Peek* IBF System is now indicated for use with allograft, including its proprietary map3® cellular allogeneic bone graft. “This indication is important news because it now gives surgeons options that they didn’t have before,” […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone